Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
27.94
-0.03 (-0.11%)
At close: Feb 12, 2026

BOM:531015 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
8.72-0.110.652.2618.46-1.62
Depreciation & Amortization
0.050.060.070.080.090.1
Asset Writedown & Restructuring Costs
0.190.19----
Other Operating Activities
-0.04-0.04-0.01000.01
Change in Accounts Receivable
-47.29-9.530.36--00.02
Change in Inventory
-15.72-0.58---2.16
Change in Accounts Payable
58.685.25-2.25-1.420.060.63
Change in Other Net Operating Assets
-120.09-18.171.2-0.950.441.35
Operating Cash Flow
-115.49-22.90.02-0.0319.052.64
Operating Cash Flow Growth
----621.97%-
Short-Term Debt Issued
---0.03--
Total Debt Issued
32.76--0.03--
Short-Term Debt Repaid
--3.03---19.8-1.9
Total Debt Repaid
-3.03-3.03---19.8-1.9
Net Debt Issued (Repaid)
29.73-3.03-0.03-19.8-1.9
Other Financing Activities
100.0150.73----
Financing Cash Flow
129.7447.7-0.03-19.8-1.9
Miscellaneous Cash Flow Adjustments
-----0-
Net Cash Flow
14.2524.80.02--0.750.74
Free Cash Flow
-115.49-22.90.02-0.0319.052.64
Free Cash Flow Growth
----621.97%-
Free Cash Flow Margin
-261.66%-283.69%---157.18%
Free Cash Flow Per Share
-18.18-4.370.00-0.013.640.50
Cash Income Tax Paid
0.32-0.23---
Levered Free Cash Flow
-125.44-29.5-1.32-3.5-0.273.25
Unlevered Free Cash Flow
-125.44-29.5-1.32-3.5-0.273.25
Change in Working Capital
-124.42-23.01-0.69-2.370.54.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.